Form 4: Eli Lilly Executive Reports Stock Transactions

Patrik Jonsson, an EVP at Eli Lilly, reported transactions involving common stock and restricted stock units on February 1, 2025.

Summary

• On February 1, 2025, Patrik Jonsson, an Executive Vice President at Eli Lilly & Co, reported transactions involving the company's stock.
• Jonsson exercised restricted stock units, converting 3,433 units into common stock.
• He also disposed of 1,535.859 shares of common stock to cover tax obligations at a price of $811.08.
• Following these transactions, Jonsson directly owns 46,480.141 shares of Eli Lilly common stock and indirectly owns 574.5 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive, with no inherent positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which is important for maintaining market confidence and regulatory compliance.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units, which vest over time and are converted to common stock.
• The disposal of shares to cover tax obligations is a common practice among executives receiving stock-based compensation.
• The filing is consistent with SEC regulations requiring timely disclosure of insider transactions.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they are part of standard executive compensation practices.
• Transparency in insider trading activity helps maintain investor confidence.

Key Dates